Oxaliplatin, one of the platinum compounds that is used as a first-line treatment for several types of cancer including breast cancer, has been shown to eradicate cancer cells by inducing cytotoxicity through targeting the ribosomal protein RPL11 49. This evidence concerns the gene RPL11 and cancer.